+44 (0) 1223 755950
+1 832 327 7413
orders@abbexa.com
Help us improve!
How easy was it for you
to use the website?
to use the website?
How can we improve?
Submit
Sales & Advice:
UK +44 (0) 1223 755950 US +1 832 327 7413 @
Fc Fragment of IgG, Low Affinity IIa, Receptor / CD32 (FCGR2A) Antibody
REQUEST MORE INFO
Catalogue No: abx001215
Price:
US$348.00
(Size: 60 µl)
Orders to United States ship from United States
Click on the image to see the image legend
FCGR2A Antibody is a Rabbit Polyclonal antibody against FCGR2A. This gene encodes one member of a family of immunoglobulin Fc receptor genes found on the surface of many immune response cells. The protein encoded by this gene is a cell surface receptor found on phagocytic cells such as macrophages and neutrophils, and is involved in the process of phagocytosis and clearing of immune complexes. Alternative splicing results in multiple transcript variants.
Research Articles on Fc Fragment of IgG, Low Affinity IIa, Receptor / CD32 (FCGR2A)
| Target | Fc Fragment of IgG, Low Affinity IIa, Receptor / CD32 (FCGR2A) |
| Clonality | Polyclonal |
| Reactivity | Human, Mouse |
| Tested Applications | IF/ICC |
| Host | Rabbit |
| Recommended dilutions | IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein corresponding to human FCGR2A |
| Isotype | IgG |
| Form | Liquid |
| Purification | Purified by affinity chromatography. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| UniProt Primary AC | P12318 (UniProt, ExPASy) |
| UniProt Secondary AC | Q8WUN1, Q8WW64 |
| Gene Symbol | FCGR2A |
| GeneID | 2212 |
| NCBI Accession | NP_001129691.1 |
| Buffer | PBS, pH 7.3, containing 0.02% sodium azide, 50% glycerol. |
| Concentration | 1 mg/ml |
| Availability | Shipped within 5-10 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
